Panakeia has been selected as a Top 10 Finalist in the AI for Good for the @EmpactVentures & @HaysTepahini5Oct 6, 20221 min read See us pitch live to win 12th October. Register to attend
Panakeia to attend and present at upcoming scientific and business conferencesCambridge, UK, 9 April 2025 – Panakeia (“the Company”), a pioneer in AI-enabled multi-omic biomarker profiling, is pleased to confirm...
Panakeia to present results of blinded multi-site validation of its AI-driven molecular profiling tool for colon cancer, PANProfiler Colon, at ASCO GI Symposium
Panakeia launches PANProfiler Colon, an AI-driven tool for precision medicine in colon cancerPANProfiler Colon determines MSI/dMMR status in minutes from colon cancer tissue samples Entirely digital, AI-driven molecular profiling...
コメント